CD38 and colorectal carcinoma: Besides that, Karakasheva et al. [55], found a significant increase in circulating CD38+ M-MDSCs, and a trend of expansion of circulating CD38+ PMN-MDSCs was detected in CRC patients, compared with healthy controls.